Ignite Creation Date:
2024-05-06 @ 5:50 PM
Last Modification Date:
2024-10-26 @ 2:36 PM
Study NCT ID:
NCT05450965
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-02
First Post:
2022-06-30
Brief Title:
Study of PLK1 Inhibitor Onvansertib in Relapsed Small Cell Lung Cancer
Sponsor:
Taofeek Owonikoko
Organization:
University of Maryland Baltimore
Organization Data
Organization:
University of Maryland Baltimore
Class:
OTHER
Study ID:
2412GCCC HP-00109457
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Taofeek Owonikoko
Lead Sponsor Class:
OTHER
Responsible Party:
Taofeek Owonikoko
Responsible Party Title:
Executive Director University of Maryland Greenebaum Compreshensive Cancer Center
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
University of Maryland Baltimore
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |
| Cardiff Oncology | INDUSTRY |